Rapid cooling of animal and human donor hearts may decrease the accumulation of a chemical that damages the tissue after transplantation, according to a new study in Nature Metabolism. These findings may lead to improved solutions for the storage of the limited pool of donor organs worldwide.
Storage of donor hearts in cold preservation solution is common practice in transplantation medicine. However, the chemical changes that occur in donor hearts during organ retrieval and the exact benefits of cold organ storage are not well understood.
Mike Murphy, Kourosh Saeb-Parsy and colleagues performed a detailed metabolic analysis of mouse, pig and human hearts stored at warm or cold temperatures. The authors found that allowing organs to remain warm after donation increased accumulation of the metabolite succinate, which damages heart tissue after organs are reconnected to blood vessels. Preventing this accumulation by administering a drug or by cooling organs improved heart-transplantation outcomes in mice.
The authors conclude that this research may lead to the formulation of new drugs to inhibit the formation of succinate in organs and improve results after transplantation.
Epidemiology: Assessing non-pharmaceutical interventions in reducing COVID-19 spreadNature Human Behaviour
Epidemiology: A website to assess COVID-19 event risk in the US in real timeNature Human Behaviour